Active ingredient
Denosumab, Zoledronsäure
Pharma Company
Amgen GmbH
Total Number of Doctors1
132 doctors
Total Number of Patients2
1,247 patients
Total minimum fees planned3
864,171.00 €

Observational Studies including Xgeva

Drug No. of doctors1 No. of patients2 Payment per patient3
Xgeva, Zoledronsäure 2 n/a 619.92 € 4 Zeitpunkte: One T&M Observation Training 284.04, Subject recruitment and enrollment procedures 165.24, Subject Information Data Form 253.80, T&M Observation (ODF) 200.88
Xgeva 120 mg Injektionslösung 30 n/a 30.00 € Aufwandsentschädigung für Ausfüllen Online Umfrage
Xgeva 100 1,247 693.00 € 7 Visiten: Einschluss Visite: 95,00, Baseline Datenerhebung: 126,00, Woche 1 bis Woche 12: 95,00, Woche 13 bis Woche 26: 95,00, Woche 27 bis Woche 39: 95,00, Woche 40 bis Woche 52: 95,00, Beobachtungsende: 95,00


Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.